Lincotek Medical is continuing to invest in new technologies, automation and workforce training.
The latest step involves expansion of the Bartlett plant in the greater Memphis, Tennessee area, where the company has recently doubled its manufacturing footprint to ~25,000 square feet with a new industrial workspace. The company has also significantly increased its coating capacity with the purchase of two new pieces of automated equipment – a CAPS Intercooler and an Air Plasma Spray (APS) – along with an automatic sandblasting machine, all created by the Group’s Equipment Division.
With the installation of a new CAPS Intercooler (proprietary technology recognized for its highly advanced porous coatings with unique material performance), Lincotek Medical can now rely on two CAPS Intercoolers in the U.S., two in the EU and two in the Asia-Pacific.
The coating investment is completed by the new APS line, which is based on the Lincotek unique twin approach, allowing for movement from one line to another achieving identical coating parameters, just by moving the production programs. The validation of Lincotek’s wide range of orthopedic device coatings is supported by multiple master files with FDA. All process inputs are monitored and recorded, assuring quality reliability and supporting OEMs in process auditing.
Lincotek Medical is also investing heavily on the additive side in the U.S. Lincotek Medical is improving further its laser-based additive manufacturing capabilities in the region. An in-house metallurgical laboratory supports production, maintaining the highest standards of quality throughout the operation.
“If it is about additive technology for medical devices,” said Francesco Bucciotti - Managing Director USA, “Lincotek Medical is the go-to partner for OEMs, ensuring reliable and cost-efficient additive device manufacturing. Starting with additive manufacturing of medical devices in 2006, the company has profound additive development and production experience, significantly reducing time to market for its customers.”
The expansion of its coatings and additive capacity will allow the company to follow market growth and will significantly increase its flexibility and production capacity: orthopedic OEMs will benefit from a reduced time to market on a global basis and stronger global risk mitigation capabilities.
Lincotek Medical, headquartered in Trento, Italy, is a global contract manufacturer for the orthopedic, trauma, spine and dental markets.